AMBER FLEMING: Open Payments
NPI 1538846746 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 38 payments from 13 companies in 2025. Trend: 2023 $702 · 2024 $1,743 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $171 |
| CVRx, Inc. | 2 | $166 |
| Lilly USA, LLC | 1 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| SCPHARMACEUTICALS INC. | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $33 |
Products named: Barostim Neo System, VERQUVO, FARXIGA, LEQVIO, FUROSCIX, CAMZYOS, JARDIANCE, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
